Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Pract
by from Morbidity and Mortality Weekly Report (MMWR) on (#6Y2PM)
This report describes ACIP's 2023 recommendation for JYNNEOS vaccine use in people 18 years and older who are at risk for mpox during an mpox outbreak.